Meetings of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria, 5246 [2024-01545]

Download as PDF 5246 Federal Register / Vol. 89, No. 18 / Friday, January 26, 2024 / Notices Dated: January 23, 2024. Lauren K. Roth, Associate Commissioner for Policy. [FR Doc. 2024–01589 Filed 1–25–24; 8:45 am] BILLING CODE 4164–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Meetings of the Presidential Advisory Council on Combating AntibioticResistant Bacteria Department of Health and Human Services, Office of the Secretary, Office of the Assistant Secretary for Health. ACTION: Notice. AGENCY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services (HHS) is hereby giving notice that a meeting is scheduled to be held for the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The meeting will be streamed live on hhs.gov/live. A preregistered public comment session will be held during the virtual meeting. Preregistration is required for members of the public who wish to present their comments live during the meeting. Individuals who wish to send in their written public comment should send an email to CARB@hhs.gov. Registration information is available on the website https://www.hhs.gov/paccarb and must be completed by February 15, 2024, for the February 22, 2024, Public Meeting. Additional information about registering for the meeting and providing public comment can be obtained at https:// www.hhs.gov/paccarb on the Upcoming Meetings page. DATES: The meeting is scheduled to be held on February 22, 2024, from 9 a.m. to 4 p.m. ET (times are tentative and subject to change). The confirmed times and agenda items for the meeting will be posted on the website for the PACCARB at https://www.hhs.gov/paccarb when this information becomes available. Preregistration for attending the meeting is strongly suggested and should be completed no later than February 15, 2024. SUMMARY: The virtual meeting can be accessed through a live webcast on the day of the meeting. Additional instructions regarding attending this meeting virtually will be posted at least one week prior to the meeting at: https:// www.hhs.gov/paccarb. FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated Federal Officer, Presidential lotter on DSK11XQN23PROD with NOTICES1 ADDRESSES: VerDate Sep<11>2014 18:02 Jan 25, 2024 Jkt 262001 Advisory Council on Combating Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. Department of Health and Human Services, 1101 Wootton Parkway, Rockville, MD 20852. Phone: 202–746– 1512; Email: CARB@hhs.gov. SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB), established by Executive Order 13676, is continued by section 505 of Public Law 116–22, the Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are governed by the provisions of the Federal Advisory Committee Act (FACA), Public Law 92– 463, as amended (5 U.S.C. app.), which sets forth standards for the formation and use of Federal advisory committees. The PACCARB shall advise and provide information and recommendations to the Secretary of Health and Human Services (Secretary) regarding programs and policies intended to reduce or combat antibioticresistant bacteria that may present a public health threat and improve capabilities to prevent, diagnose, mitigate, or treat such resistance. The PACCARB shall function solely for advisory purposes. Such advice, information, and recommendations may be related to improving: the effectiveness of antibiotics; research and advanced research on, and the development of, improved and innovative methods for combating or reducing antibiotic resistance, including new treatments, rapid point-of-care diagnostics, alternatives to antibiotics, including alternatives to animal antibiotics, and antimicrobial stewardship activities; surveillance of antibiotic-resistant bacterial infections, including publicly available and up-to-date information on resistance to antibiotics; education for health care providers and the public with respect to up-to-date information on antibiotic resistance and ways to reduce or combat such resistance to antibiotics related to humans and animals; methods to prevent or reduce the transmission of antibiotic-resistant bacterial infections; including stewardship programs; and coordination with respect to international efforts in order to inform and advance the United States capabilities to combat antibiotic resistance. The February 22, 2024, meeting will serve as a critical platform for key international stakeholders, and nongovernment organizations, to share their latest strategies and progress in tackling PO 00000 Frm 00047 Fmt 4703 Sfmt 4703 the global threat of antimicrobial resistance. The focus will be on both showcasing successful international and regional initiatives and identifying areas for enhanced collaboration and knowledge exchange. The meeting agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are tentative and subject to change. Instructions regarding attending the meeting virtually will be posted at least one week prior to the meeting at: https://www.hhs.gov/paccarb. Members of the public will have the opportunity to provide comments virtually during the February meeting by pre-registering online at https:// www.hhs.gov/paccarb; pre-registration is required for participation in this session with limited spots available. Written public comments can also be emailed to CARB@hhs.gov by midnight February 15, 2024, and should be limited to no more than one page. All public comments received prior to February 15, 2024, will be provided to the PACCARB members. Dated: January 10, 2024. Jomana F. Musmar, Designated Federal Officer, Presidential Advisory Council on Combating AntibioticResistant Bacteria, Office of the Assistant Secretary for Health. [FR Doc. 2024–01545 Filed 1–25–24; 8:45 am] BILLING CODE 4150–44–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Center for Scientific Review Special Emphasis Panel; Member Conflict: Biological Chemistry and Macromolecular Biophysics. Date: February 21, 2024. Time: 10:00 a.m. to 6:00 p.m. E:\FR\FM\26JAN1.SGM 26JAN1

Agencies

DEPARTMENT OF HEALTH AND HUMAN SERVICES

[Federal Register Volume 89, Number 18 (Friday, January 26, 2024)]
[Notices]
[Page 5246]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-01545]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meetings of the Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria

AGENCY: Department of Health and Human Services, Office of the 
Secretary, Office of the Assistant Secretary for Health.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services (HHS) is hereby giving notice 
that a meeting is scheduled to be held for the Presidential Advisory 
Council on Combating Antibiotic-Resistant Bacteria (PACCARB). The 
meeting will be streamed live on hhs.gov/live. A pre-registered public 
comment session will be held during the virtual meeting. Pre-
registration is required for members of the public who wish to present 
their comments live during the meeting. Individuals who wish to send in 
their written public comment should send an email to [email protected]. 
Registration information is available on the website https://www.hhs.gov/paccarb and must be completed by February 15, 2024, for the 
February 22, 2024, Public Meeting. Additional information about 
registering for the meeting and providing public comment can be 
obtained at https://www.hhs.gov/paccarb on the Upcoming Meetings page.

DATES: The meeting is scheduled to be held on February 22, 2024, from 9 
a.m. to 4 p.m. ET (times are tentative and subject to change). The 
confirmed times and agenda items for the meeting will be posted on the 
website for the PACCARB at https://www.hhs.gov/paccarb when this 
information becomes available. Pre-registration for attending the 
meeting is strongly suggested and should be completed no later than 
February 15, 2024.

ADDRESSES: The virtual meeting can be accessed through a live webcast 
on the day of the meeting. Additional instructions regarding attending 
this meeting virtually will be posted at least one week prior to the 
meeting at: https://www.hhs.gov/paccarb.

FOR FURTHER INFORMATION CONTACT: Jomana Musmar, M.S., Ph.D., Designated 
Federal Officer, Presidential Advisory Council on Combating Antibiotic-
Resistant Bacteria, Office of the Assistant Secretary for Health, U.S. 
Department of Health and Human Services, 1101 Wootton Parkway, 
Rockville, MD 20852. Phone: 202-746-1512; Email: [email protected].

SUPPLEMENTARY INFORMATION: The Presidential Advisory Council on 
Combating Antibiotic-Resistant Bacteria (PACCARB), established by 
Executive Order 13676, is continued by section 505 of Public Law 116-
22, the Pandemic and All-Hazards Preparedness and Advancing Innovation 
Act of 2019 (PAHPAIA). Activities and duties of the PACCARB are 
governed by the provisions of the Federal Advisory Committee Act 
(FACA), Public Law 92-463, as amended (5 U.S.C. app.), which sets forth 
standards for the formation and use of Federal advisory committees.
    The PACCARB shall advise and provide information and 
recommendations to the Secretary of Health and Human Services 
(Secretary) regarding programs and policies intended to reduce or 
combat antibiotic-resistant bacteria that may present a public health 
threat and improve capabilities to prevent, diagnose, mitigate, or 
treat such resistance. The PACCARB shall function solely for advisory 
purposes.
    Such advice, information, and recommendations may be related to 
improving: the effectiveness of antibiotics; research and advanced 
research on, and the development of, improved and innovative methods 
for combating or reducing antibiotic resistance, including new 
treatments, rapid point-of-care diagnostics, alternatives to 
antibiotics, including alternatives to animal antibiotics, and 
antimicrobial stewardship activities; surveillance of antibiotic-
resistant bacterial infections, including publicly available and up-to-
date information on resistance to antibiotics; education for health 
care providers and the public with respect to up-to-date information on 
antibiotic resistance and ways to reduce or combat such resistance to 
antibiotics related to humans and animals; methods to prevent or reduce 
the transmission of antibiotic-resistant bacterial infections; 
including stewardship programs; and coordination with respect to 
international efforts in order to inform and advance the United States 
capabilities to combat antibiotic resistance.
    The February 22, 2024, meeting will serve as a critical platform 
for key international stakeholders, and non-government organizations, 
to share their latest strategies and progress in tackling the global 
threat of antimicrobial resistance. The focus will be on both 
showcasing successful international and regional initiatives and 
identifying areas for enhanced collaboration and knowledge exchange. 
The meeting agenda will be posted on the PACCARB website at https://www.hhs.gov/paccarb when it has been finalized. All agenda items are 
tentative and subject to change. Instructions regarding attending the 
meeting virtually will be posted at least one week prior to the meeting 
at: https://www.hhs.gov/paccarb.
    Members of the public will have the opportunity to provide comments 
virtually during the February meeting by pre-registering online at 
https://www.hhs.gov/paccarb; pre-registration is required for 
participation in this session with limited spots available. Written 
public comments can also be emailed to [email protected] by midnight 
February 15, 2024, and should be limited to no more than one page. All 
public comments received prior to February 15, 2024, will be provided 
to the PACCARB members.

    Dated: January 10, 2024.
Jomana F. Musmar,
Designated Federal Officer, Presidential Advisory Council on Combating 
Antibiotic-Resistant Bacteria, Office of the Assistant Secretary for 
Health.
[FR Doc. 2024-01545 Filed 1-25-24; 8:45 am]
BILLING CODE 4150-44-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.